Multi-protein biomarker panels combining alpha-synuclein with tau and amyloid-beta — alpha-synuclein Parkinson's disease
Can combinations of alpha-synuclein with tau or amyloid biomarkers improve Parkinson's disease diagnosis and prognosis?
sparse evidenceInterestingness: 51.0
Discovered by InTree.AI — analyzing 250M+ scientific papers
Multi-protein biomarker panels combining alpha-synuclein with tau and amyloid-beta — alpha-synuclein Parkinson's disease — Research Gap | InTree.AI | InTree